Hot Investor Mandate 10: European VC Seeking Medtech and Digital Health Opportunities in Cardiovascular, Neurology, Oncology Indications

23 Nov

A venture capital firm with offices in Europe and USA manages over $230M investing in medical technologies and healthcare IT companies with a stage agnostic strategy. The initial investment size ranges from $0.4 million for seed stage companies to $2.5 million for later stage ventures, and the firm reserves significant capital for follow on investments. The firm is primarily focused on Europe, but has also done investments in the USA and Israel.

The firm is currently looking for new investment opportunities in medical devices, diagnostics and digital health sectors. The firm has a sector focus on selected therapeutic areas including cardiovascular, neurology and oncology although the firm is opportunistic in other areas. For digital health, the firm prefers to invest in companies developing platforms, solutions and software.

The firm seeks to invest in both public and private companies and will consider pre-revenue companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: